RDZN vs AKTX

Comparison between Roadzen Inc (RDZN, Company) and Akari Therapeutics Plc (AKTX, Company).

RDZN is from the Technology sector, while AKTX is from the Healthcare sector.

RDZN vs AKTX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RDZN(COMPANY)	AKTX(COMPANY)
Market Cap	$149M	$148M
Max Drawdown	90.32%	99.99%
Sharpe Ratio	0.94	0.32
5Y Beta	1.93	0.67
Industry	Software - Application	Biotechnology
P/E Ratio	-9.42	-8.66
PEG Ratio	N/A	0.00
Debt to Equity	-39.88%	0.00%
Free Cash Flow Yield	-13.58%	-6.52%
P/S Ratio	3.15	478368.50
P/B Ratio	N/A	1.14

Market Cap

Winner

RDZN

$149M

AKTX

$148M

Max Drawdown

Winner

RDZN

90.32%

AKTX

99.99%

Sharpe Ratio

Winner

RDZN

0.94

AKTX

0.32

5Y Beta

RDZN

1.93

Winner

AKTX

0.67

Industry

RDZN

Software - Application

AKTX

Biotechnology

P/E Ratio

Winner

RDZN

-9.42

AKTX

-8.66

PEG Ratio

RDZN

N/A

AKTX

0.00

Debt to Equity

Winner

RDZN

-39.88%

AKTX

0.00%

Free Cash Flow Yield

RDZN

-13.58%

Winner

AKTX

-6.52%

P/S Ratio

Winner

RDZN

3.15

AKTX

478368.50

P/B Ratio

RDZN

N/A

AKTX

1.14

RDZN vs AKTX - Historical Returns

Returns include dividend reinvestment.

Period	RDZN	AKTX
1 month	-4.47%	+168.15%
3 months	+29.55%	+52.78%
6 months	+3.64%	+11.14%
1 year	+73.67%	-70.61%
5 years(CAGR)	N/A	-59.77%
10 years(CAGR)	N/A	-48.61%
Max(CAGR)	-39.20%	-50.01%

RDZN

-4.47%

Winner

AKTX

+168.15%

RDZN

+29.55%

Winner

AKTX

+52.78%

RDZN

+3.64%

Winner

AKTX

+11.14%

Winner

RDZN

+73.67%

AKTX

-70.61%

5Y(CAGR)

RDZN

N/A

AKTX

-59.77%

10Y(CAGR)

RDZN

N/A

AKTX

-48.61%

Max(CAGR)

Winner

RDZN

-39.20%

AKTX

-50.01%

RDZN vs AKTX - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	RDZN	AKTX
2026	-27.85%	+29.91%
2025	-3.21%	-76.12%
2024	-54.49%	-57.88%
2023	-22.53%	-68.39%
2022	N/A	-68.88%
2021	N/A	-17.13%
2020	N/A	+6.32%
2019	N/A	+5.11%
2018	N/A	-64.24%
2017	N/A	-42.27%
2016	N/A	-48.42%
2015	N/A	-53.97%